Role Responsibilities:
- Support development and execution of U.S. medical strategies and tactics for Vyndamax.
- Collaborate cross-functionally (commercial, field medical, HEOR, digital, U.S. medical information) to enhance and deliver U.S. medical plans.
- Serve as a Medical Affairs reviewer in the U.S. Review Committee (RC) to ensure scientific accuracy and compliance of promotional and non-promotional materials.
- Act as a scientific resource on ATTR-CM disease state, clinical data, product labeling, and competitive landscape.
- Support and coordinate U.S. medical congress activities (coverage planning, session prioritization, onsite support).
- Provide scientific input for medical/educational content ensuring accuracy, clinical relevance, and strategy alignment.
- Support customer insights and insight-generation activities (e.g., advisory boards) with Field Medical and internal stakeholders.
- Deliver therapeutic area and product training to cross-functional colleagues.
- Partner with U.S. Medical Information for expert input into Medical Letters and response documents.
Qualifications / Skills:
- Doctoral degree in clinical/pharmacy (Ph.D./Pharm.D) with 5+ years; Masterβs with 7+ years; Bachelorβs with 8+ years.
- Preferred: Heart Failure/ATTR-CM knowledge and experience.
- Understanding of drug development process; health care economics; strong analytical skills.
- Customer-oriented, strategic thinking, deadline management, creativity/resourcefulness, strong communication/presentation skills.
Other Job Details / Application:
- Last date to apply: July 13, 2026. Work location: NYHQ. Relocation package: No.
- Annual base salary range: $176,600β$294,300; bonus target 20% of base; eligibility for long-term incentives and comprehensive benefits (incl. 401(k)).